key: cord-0912218-jlyky0sx
authors: Mohta, Alpana; Kumar Sharma, Manoj; Chand Ghiya, Bhikam; Dutt Mehta, Rajesh
title: Clearance of Recalcitrant Verruca Plana following COVID-19 Vaccination
date: 2022-03-16
journal: JAAD Int
DOI: 10.1016/j.jdin.2022.02.007
sha: e54ad17d369423cf00b195bf2e90df3cc4822f72
doc_id: 912218
cord_uid: jlyky0sx

nan

To the editor, 2 Human papillomavirus (HPV) is a keratinocyte infecting virus. Despite the presence of a wide 3 armamentarium for the management of warts, they are often notoriously resistant to treatment. 4 Of late, various authors have reported the development of many inflammatory dermatoses and 5 cutaneous adverse events following the administration of COVID-19 vaccination. Herein, we 6 report a case of spontaneous clearance of warts following two doses of the recombinant 7 ChAdOx1 nCoV-19 coronavirus vaccine.

A 27-year-old male patient presented to us with multiple verruca plana over the mandibular 9 and bilateral temple area for 12 months (figure 1a, 1b). Previously, he was subjected to 2 10 sessions of radiofrequency ablation 10 months back. Within 2 months of treatment, his warts 11 recurred. Following this recurrence, intralesional immunotherapy using MMR vaccine was 12 advised which the patient refused to. Due to the absence of viremia, warts often escape the innate immune system. Spontaneous 19 reduction in verruca was been sparsely reported after COVID-19 infection, with only two 20 reported cases so far. [1, 2] Erkayman has proposed that due to a complex interaction between the 21 humoral and cellular immunity following COVID-19, warts may resolve on their own. The 

Clearance of longstanding treatment-resistant warts during 44 COVID-19 in a transplant recipient